Is Viatris Stock Outperforming the Dow?

Canonsburg, Pennsylvania-based Viatris Inc. (VTRS) is a healthcare company that provides a diverse portfolio of branded, generic, and complex medicines to patients. Valued at a market cap of $13.4 billion, the company's product offerings span major therapeutic categories such as cardiovascular, oncology, central nervous system, and infectious disease treatments.

Companies worth $10 billion or more are typically classified as “large-cap stocks,” and Viatris fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the drug manufacturers - specialty & generic industry. The company leverages a wide manufacturing and distribution network, emphasizing access to affordable medicines, operational efficiency, and sustainable cash flow generation.